$317.97+0.78%Close 13 Nov 2026 · Market value $114.9B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
CME Group is valued at $114.9B on its latest close. Its price is 26.0 times its earnings.
| Market value | $114.9B |
|---|
| Enterprise value | $116.2B |
|---|
| Price / earnings | 26.02 |
|---|
| Price / sales | 16.47 |
|---|
| Price / book | 4.32 |
|---|
| EV / EBITDA | 23.66 |
|---|
| EV / sales | 16.67 |
|---|
| Price / free cash flow | 26.51 |
|---|
| Price / free cash flow, own 5-year average | 25.17 |
|---|
| EV / EBIT | 25.41 |
|---|
| EV / free cash flow | 26.85 |
|---|
| Free cash flow yield | 3.8% |
|---|
| Dividend yield | 3.6% |
|---|
Share price
| Latest close | $317.97 |
|---|
| Day's change | +0.8% |
|---|
| 52-week high | $329.16 |
|---|
| 52-week low | $218.31 |
|---|
| From 52-week high | −3.4% |
|---|
| Return · 1 month | +8.2% |
|---|
| Return · 3 months | +17.4% |
|---|
| Return · year to date | +16.4% |
|---|
| Return · 1 year | +13.7% |
|---|
| Beta · 1 year against the S&P 500 | −0.30 |
|---|
| 50-day average | $286.01 |
|---|
| 200-day average | $281.56 |
|---|
| RSI 14 | 71.6 |
|---|
| Average volume · 20 sessions | 2.0M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Operating margin | 64.9% |
|---|
| Net margin | 62.5% |
|---|
| Free cash flow margin | 64.3% |
|---|
| Return on equity | 14.8% |
|---|
| Return on assets | 1.9% |
|---|
| Return on invested capital | 9.4% |
|---|
| Return on invested capital, 5-year average | 7.6% |
|---|
| Return on capital employed | 11.5% |
|---|
| Stock-based compensation / revenue | 1.5% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $4.42B |
|---|
| Total debt | $3.76B |
|---|
| Net debt | −$784.7M |
|---|
| Current ratio | 1.03 |
|---|
| Quick ratio | 0.02 |
|---|
| Debt / equity | 0.13 |
|---|
| Net debt / EBITDA | −0.17 |
|---|
| Interest coverage | 24.39 |
|---|
Growth
| Revenue, latest quarter on a year | +13.0% |
|---|
| Revenue, twelve months on a year | +9.0% |
|---|
| EPS, latest quarter on a year | +16.1% |
|---|
| EPS, twelve months on a year | +18.6% |
|---|
| Revenue, 5-year compound | +6.0% |
|---|
| Revenue, 10-year compound | +7.0% |
|---|
| Net income, 5-year compound | +14.1% |
|---|
| Free cash flow, 5-year compound | +10.7% |
|---|
| EPS, 5-year compound | +13.7% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 360M |
|---|
| Shares outstanding, 5-year compound | +0.1% |
|---|
| Dividends per share | $5.00 |
|---|
| Dividend payout | 96.6% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $1.26B |
|---|
| Effective tax rate | 23.6% |
|---|
CME in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.